Literature DB >> 21780899

Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions.

Wim Laleman1, Len Verbeke, Philippe Meersseman, Joost Wauters, Jos van Pelt, David Cassiman, Alexander Wilmer, Chris Verslype, Frederik Nevens.   

Abstract

In recent years, acute-on-chronic liver failure has been recognized as a specific clinical form of liver failure associated with cirrhosis. The syndrome refers to an acute deterioration of liver function and subsequently of other end organs over a period of weeks following a precipitating event in a patient with previously well- or reasonably well-compensated cirrhosis. These precipitating events include either an indirect (e.g., variceal hemorrhage, sepsis) or a direct (e.g., drug-induced) hepatotoxic factor. The short-term mortality for this condition is more than 50%. At present, considerable efforts are ongoing to better characterize the syndrome, to gain further insight into its pathophysiology and to optimize therapy. This article aims to highlight the current concepts of these various aspects.

Entities:  

Mesh:

Year:  2011        PMID: 21780899     DOI: 10.1586/egh.11.47

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  33 in total

1.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Authors:  Shiv Kumar Sarin; Ashok Choudhury; Manoj K Sharma; Rakhi Maiwall; Mamun Al Mahtab; Salimur Rahman; Sanjiv Saigal; Neeraj Saraf; A S Soin; Harshad Devarbhavi; Dong Joon Kim; R K Dhiman; Ajay Duseja; Sunil Taneja; C E Eapen; Ashish Goel; Q Ning; Tao Chen; Ke Ma; Z Duan; Chen Yu; Sombat Treeprasertsuk; S S Hamid; Amna S Butt; Wasim Jafri; Akash Shukla; Vivek Saraswat; Soek Siam Tan; Ajit Sood; Vandana Midha; Omesh Goyal; Hasmik Ghazinyan; Anil Arora; Jinhua Hu; Manoj Sahu; P N Rao; Guan H Lee; Seng G Lim; Laurentius A Lesmana; Cosmas Rinaldi Lesmana; Samir Shah; V G Mohan Prasad; Diana A Payawal; Zaigham Abbas; A Kadir Dokmeci; Jose D Sollano; Gian Carpio; Ananta Shresta; G K Lau; Md Fazal Karim; Gamal Shiha; Rino Gani; Kemal Fariz Kalista; Man-Fung Yuen; Seema Alam; Rajeev Khanna; Vikrant Sood; Bikrant Bihari Lal; Viniyendra Pamecha; Ankur Jindal; V Rajan; Vinod Arora; Osamu Yokosuka; Madunil A Niriella; Hai Li; Xiaolong Qi; Atsushi Tanaka; Satoshi Mochida; Dominic Ray Chaudhuri; Ed Gane; Khin Maung Win; Wei Ting Chen; Mohd Rela; Dharmesh Kapoor; Amit Rastogi; Pratibha Kale; Archana Rastogi; Chhagan Bihari Sharma; Meenu Bajpai; Virender Singh; Madhumita Premkumar; Sudhir Maharashi; A Olithselvan; Cyriac Abby Philips; Anshu Srivastava; Surender K Yachha; Zeeshan Ahmad Wani; B R Thapa; Anoop Saraya; Ashish Kumar; Manav Wadhawan; Subash Gupta; Kaushal Madan; Puja Sakhuja; Vivek Vij; Barjesh C Sharma; Hitendra Garg; Vishal Garg; Chetan Kalal; Lovkesh Anand; Tanmay Vyas; Rajan P Mathur; Guresh Kumar; Priyanka Jain; Samba Siva Rao Pasupuleti; Yogesh K Chawla; Abhijit Chowdhury; Shahinul Alam; Do Seon Song; Jin Mo Yang; Eileen L Yoon
Journal:  Hepatol Int       Date:  2019-06-06       Impact factor: 6.047

2.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

3.  Clinical profile, natural history, and predictors of mortality in patients with acute-on-chronic liver failure (ACLF).

Authors:  Ivana Mikolasevic; Sandra Milic; Mladen Radic; Lidija Orlic; Zeljka Bagic; Davor Stimac
Journal:  Wien Klin Wochenschr       Date:  2015-03-28       Impact factor: 1.704

4.  IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice.

Authors:  Jue Wei; Min Shi; Wei-Qi Wu; Hui Xu; Ting Wang; Na Wang; Jia-Li Ma; Yu-Gang Wang
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

5.  Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial.

Authors:  Yu-Ming Guo; Feng-Yi Li; Man Gong; Lin Zhang; Jia-Bo Wang; Xiao-He Xiao; Jun Li; Yan-Ling Zhao; Li-Fu Wang; Xiao-Feng Zhang
Journal:  Chin J Integr Med       Date:  2016-05-24       Impact factor: 1.978

Review 6.  Acute-on-chronic Liver Failure.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Curr Gastroenterol Rep       Date:  2016-12

Review 7.  Hepatitis E and Acute-on-Chronic Liver Failure.

Authors:  Ashish Kumar; Vivek A Saraswat
Journal:  J Clin Exp Hepatol       Date:  2013-09-16

Review 8.  A guide to the management of tuberculosis in patients with chronic liver disease.

Authors:  Radha K Dhiman; Vivek A Saraswat; Harshal Rajekar; Chandrasekhar Reddy; Yogesh K Chawla
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 9.  Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; María Luisa Gutiérrez-García; Sonia Alonso-López; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure (ACLF).

Authors:  Archana Rastogi; Chhagan Bihari; Rakhi Maiwall; Arvind Ahuja; Manoj Kumar Sharma; Ashish Kumar; Shiv Kumar Sarin
Journal:  Virchows Arch       Date:  2012-08-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.